Scholarlink

Purpose <p>To assess the clinical presentation and the long-term outcomes of pituitary apoplexy in a large cohort of patients with PitNETs.</p> Methods <p>Retrospective multicenter study, including 177 patients (median age 51 years; 111 males and 66 females) from ten Italian referral centers for PitNETs. All patients &gt; 18 years old with a diagnosis of pituitary apoplexy based on clinical and radiological features were eligible. Clinical and biochemical assessment was performed at the time of apoplexy and after at least 12 months follow-up.</p> Results <p>At the time of apoplexy, patients with macroadenomas had a higher frequency of headache (83% vs. 50%, <i>p</i> = 0.012), visual field defects (58% vs. 25%, <i>p</i> = 0.035) and symptoms consistent with hypopituitarism (68% vs. 33%, <i>p</i> = 0.024) compared to microadenomas. Men were more likely to present with central adrenal insufficiency (62% vs. 44%; <i>p</i> = 0.028), central hypogonadism (65% vs. 37%, <i>p</i> &lt; 0.001), growth hormone deficiency (35% vs. 19%, <i>p</i> = 0.035) and undergo surgery (69% vs. 31%, <i>p</i> = 0.005). Age also influenced clinical presentation, with central adrenal insufficiency (<i>p</i> = 0.0021), central hypogonadism (<i>p</i> = 0.0045) and growth hormone deficiency (<i>p</i> = 0.0048) being more prevalent in older patients. In terms of outcomes, no differences were observed between patients who underwent surgery and those who did not, except for central hypothyroidism, more prevalent in surgically treated patients (63% vs. 46%, <i>p</i> = 0.041). Nevertheless, 70% of surgically treated patients had pre-existing central hypothyroidism at the time of apoplexy.</p> Conclusion <p>Tumor size, male sex and age have been demonstrated to affect apoplexy clinical presentation, while the different management strategies do not impact the long-term outcomes.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Clinical presentation and outcomes of pituitary apoplexy in patients with PitNETs: a real world Italian multicenter study

  • 期刊论文

  • 发表日期：

    2025年10月31日

查看全文
  • Maria Francesca Birtolo,
  • Federico Gatto,
  • Renata Simona Auriemma,
  • Carolina Di Somma,
  • Rossana Arianna,
  • Diego Criminelli Rossi,
  • Michela Sibilla,
  • Silvia Grottoli,
  • Filippo Ceccato,
  • Irene Tizianel,
  • Salvatore Cannavò,
  • Filippo Flavio Angileri,
  • Roberto Baldelli,
  • Francesca Rota,
  • Maria Rosaria Ambrosio,
  • Marta Bondanelli,
  • Sabrina Chiloiro,
  • Antonio Bianchi,
  • Alessandra Mangone,
  • Giovanna Mantovani,
  • Gherardo Mazziotti,
  • Andrea Lania

摘要

Purpose

To assess the clinical presentation and the long-term outcomes of pituitary apoplexy in a large cohort of patients with PitNETs.

Methods

Retrospective multicenter study, including 177 patients (median age 51 years; 111 males and 66 females) from ten Italian referral centers for PitNETs. All patients > 18 years old with a diagnosis of pituitary apoplexy based on clinical and radiological features were eligible. Clinical and biochemical assessment was performed at the time of apoplexy and after at least 12 months follow-up.

Results

At the time of apoplexy, patients with macroadenomas had a higher frequency of headache (83% vs. 50%, p = 0.012), visual field defects (58% vs. 25%, p = 0.035) and symptoms consistent with hypopituitarism (68% vs. 33%, p = 0.024) compared to microadenomas. Men were more likely to present with central adrenal insufficiency (62% vs. 44%; p = 0.028), central hypogonadism (65% vs. 37%, p < 0.001), growth hormone deficiency (35% vs. 19%, p = 0.035) and undergo surgery (69% vs. 31%, p = 0.005). Age also influenced clinical presentation, with central adrenal insufficiency (p = 0.0021), central hypogonadism (p = 0.0045) and growth hormone deficiency (p = 0.0048) being more prevalent in older patients. In terms of outcomes, no differences were observed between patients who underwent surgery and those who did not, except for central hypothyroidism, more prevalent in surgically treated patients (63% vs. 46%, p = 0.041). Nevertheless, 70% of surgically treated patients had pre-existing central hypothyroidism at the time of apoplexy.

Conclusion

Tumor size, male sex and age have been demonstrated to affect apoplexy clinical presentation, while the different management strategies do not impact the long-term outcomes.